Patents by Inventor Delphine Rolland

Delphine Rolland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for joining a micorelectronic chip to a wire element
    Patent number: 11081466
    Abstract: A method for joining a microelectronic chip to at least one wire element comprises a first step of applying a cover to a first face of the microelectronic chip, the cover being configured to form, with the first face, at least one temporary side groove. The method additionally comprises a step of inserting the wire element into the temporary groove. The method further comprises a step of attaching the wire element to the microelectronic chip. The method additionally comprises a step of removing the cover from the microelectronic chip.
    Type: Grant
    Filed: April 16, 2018
    Date of Patent: August 3, 2021
    Assignee: PRIMO1D
    Inventors: Delphine Rolland, Christopher Mackanic, Gianfranco Andia Vera, Emmanuel Arene
  • METHOD FOR JOINING A MICORELECTRONIC CHIP TO A WIRE ELEMENT
    Publication number: 20200335475
    Abstract: A method for joining a microelectronic chip to at least one wire element comprises: a first step of applying a cover to a first face of the microelectronic chip, the cover being configured to form, with the first face, at least one temporary side groove; a step of inserting the wire element into the temporary groove; a step of attaching the wire element to the microelectronic chip; and a step of removing the cover from the microelectronic chip.
    Type: Application
    Filed: April 16, 2018
    Publication date: October 22, 2020
    Applicants: PRIMO1D, PRIMO1D
    Inventors: Delphine Rolland, Christopher Mackanic, Gianfranco Andia Vera, Emmanuel Arene
  • Recurrent gene fusions in cutaneous CD30-positive lymphoproliferative disorders
    Patent number: 10590488
    Abstract: Provided herein are kits, compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to recurrent gene fusions (e.g., recurrent translocations involving TYK2) as diagnostic markers and clinical targets for cutaneous CD30-positive lymphoproliferative disorders (e.g., lymphomatoid papulosis; primary cutaneous anaplastic large cell lymphoma).
    Type: Grant
    Filed: January 29, 2016
    Date of Patent: March 17, 2020
    Assignee: The Regents of the University of Michigan
    Inventors: Kojo Elenitoba-Johnson, Mark J. Kiel, Delphine Rolland, Bryan L. Betz, Nathanael G. Bailey, Thirunavukkarasu Velusamy, Megan Lim
  • RECURRENT GENE FUSIONS IN CUTANEOUS CD30-POSITIVE LYMPHOPROLIFERATIVE DISORDERS
    Publication number: 20180010196
    Abstract: Provided herein are kits, compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to recurrent gene fusions (e.g., recurrent translocations involving TYK2) as diagnostic markers and clinical targets for cutaneous CD30-positive lymphoproliferative disorders (e.g., lymphomatoid papulosis; primary cutaneous anaplastic large cell lymphoma).
    Type: Application
    Filed: January 29, 2016
    Publication date: January 11, 2018
    Inventors: Kojo Elenitoba-Johnson, Mark J. Kiel, Delphine Rolland, Bryan L. Betz, Nathanael G. Bailey, Thirunavukkarasu Velusamy, Megan Lim
  • Compositions and methods relating to fusion protein biomarkers
    Patent number: 9284594
    Abstract: The present invention provides fusion proteins as biomarkers specific for chromosomal translocation-based conditions (e.g., cancer), related methods for detecting fusion protein biomarkers associated with chromosomal translocation-based conditions, related methods for quantifying amount of fusion protein expression, and related methods for diagnosing chromosomal translocation-based conditions through detection of such fusion protein biomarkers. Such fusion protein biomarkers and related methods additionally find use in research settings.
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: March 15, 2016
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Kojo Elenitoba-Johnson, Delphine Rolland, Venkatesha Basrur, Kevin P. Conlon, Megan S. Lim
  • METHODS AND BIOMARKERS FOR DETECTION AND TREATMENT OF MATURE T-CELL LEUKEMIA
    Publication number: 20150050274
    Abstract: The present invention relates to methods and biomarkers for detection and characterization of mature T-cell neoplasias/leukemias (e.g., T-cell prolymphocytic leukemia, Sezary syndrome) in biological samples (e.g., tissue samples, blood samples, plasma samples, cell samples, serum samples).
    Type: Application
    Filed: August 14, 2014
    Publication date: February 19, 2015
    Inventors: Kojo Elenitoba-Johnson, Mark J. Kiel, Thirunavukkarasu Velusamy, Anagh Sahasrabuddhe, Delphine Rolland, Megan Lim
  • COMPOSITIONS AND METHODS RELATING TO FUSION PROTEIN BIOMARKERS
    Publication number: 20150031061
    Abstract: The present invention provides fusion proteins as biomarkers specific for chromosomal translocation-based conditions (e.g., cancer), related methods for detecting fusion protein biomarkers associated with chromosomal translocation-based conditions, related methods for quantifying amount of fusion protein expression, and related methods for diagnosing chromosomal translocation-based conditions through detection of such fusion protein biomarkers. Such fusion protein biomarkers and related methods additionally find use in research settings.
    Type: Application
    Filed: June 27, 2014
    Publication date: January 29, 2015
    Inventors: Kojo Elenitoba-Johnson, Delphine Rolland, Venkatesha Basrur, Kevin P. Conlon, Megan S. Lim